BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Market Cap	755.55M -13.5%
Revenue (ttm)	262.66M -10.2%
Net Income	42.43M -3.6%
EPS	1.65 -4.0%
Shares Out	25.61M
PE Ratio	17.88
Forward PE	n/a
Dividend	1.50 (5.08%)
Ex-Dividend Date	Aug 7, 2025

Volume	24,171
Average Volume	13,023
Open	29.45
Previous Close	29.50
Day's Range	29.20 - 29.60
52-Week Range	28.05 - 35.80
Beta	0.23
RSI	49.13
Earnings Date	Mar 27, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment; various reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin testing system, r...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 91
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6662

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.